Table 2 Metabolic and anthropometric profile of breast cancer cases and control groups
Characteristics | Breast cancer N = 112 No. (%) | Control N = 112 No. (%) | Total N = 224 No. (%) | p-value * |
|---|---|---|---|---|
Metabolic profiles (mean ± SD) | ||||
Total cholesterol (mg/dl) | 212.55 ± 42.1 | 192.3 ± 40.04 | 202.4 ± 42.2 | < 0.001 |
HDL-c (mg/dl) | 40.01 ± 8.3 | 47.6 ± 11.4 | 44.3 ± 10.5 | < 0.001 |
TG (mg/dl) | 214.6 ± 103.6 | 151.6 ± 78.4 | 183.1 ± 96.9 | < 0.00 |
FBG (mg/dl) | 120.8 ± 60.9 | 95.8 ± 28.9 | 108.3 ± 49.1 | < 0.001 |
FIR | 0.368 ± 0.236 | 0.355 ± 0.193 | 0.361 ± 0.215 | 0.936 |
SBP | 120.9 ± 7.5 | 118.4 ± 7.4 | 119.7 ± 7.5 | 0.012 |
DBP | 80.4 ± 5.97 | 79.9 ± 4.3 | 80.5 ± 5.2 | 0.482 |
Anthropometric profiles (mean ± SD) | ||||
Weight (kg) | 77.6 ± 14.9 | 71.2 ± 13.5 | 74.4 ± 14.5 | < 0.001 |
Waist circumference (cm) | 90.5 ± 18.0 | 88.2 ± 15.1 | 89.3 ± 16.6 | 0.289 |
BMI (kg/m2) | 29.7 ± 5.7 | 26.8 ± 4.8 | 28.3 ± 5.5 | < 0.001 |
BMI classification (kg/m2) | ||||
Underweight | 1 (0.9) | 3 (2.7) | 4 (1.8) | P-value for linear trend 0.002 |
Normal | 17 (15.2) | 39 (34.8) | 56 (25.0) | |
Overweight | 43 (38.4) | 42 (37.5) | 85 (37.9) | |
Obese | 43 (38.4) | 25 (22.3) | 68 (30.4) | |
Morbid obese | 8 (7.1) | 3 (2.7) | 11 (4.9) | |